|Number of pages||2|
|Journal||The Lancet Diabetes and Endocrinology|
|Publication status||Published (in print/issue) - Aug 2021|
Bibliographical noteFunding Information:
CWlR serves on advisory boards for Novo Nordisk, Johnson & Johnson, and Herbalife; has received grant funding (to his institution) from the Irish Research Council, the Science Foundation Ireland, the Innovative Medicines Initiative of the EU, and the Health Research Board Ireland; has received honoraria, or payments for lectures, speakers bureaus, presentations, or education events, from Novo Nordisk, Johnson & Johnson, and Herbalife; has received financial support for attendance at educational events or travel from Novo Nordisk, Johnson & Johnson, and Herbalife; and is a board member of the Irish Society for Nutrition and Metabolism. KJN declares no competing interests.
- Bariatric Surgery/adverse effects